Stealth Bay Area medical device maker Cala Health looks to have closed out an $18 million Series A round, according to a regulatory filing. Investors in the company include Johnson & Johnson Development Corporation, Lux Capital and Lightstone Ventures.
The Stanford University spinout, founded in 2014, is simply saying on its website that it’s developing “novel therapies based on recent neuroscience discoveries.” However, an alumni briefing from the Stanford Biodesign program says a little more: That it’s building a minimally invasive “wearable therapy for hand tremor.”
